D75.1
D75.1: Secondary polycythemia
Billable / specific codeICD-10-CM
D75.1 is a billable, specific ICD-10-CM code for secondary polycythemia. It is valid for submission on a claim.
Check D75.1 with the rest of the claim: free scrubberExcludes1: never code together
These conditions cannot occur together. Billing both on the same encounter is a denial.
Inclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Acquired polycythemia
- Emotional polycythemia
- Erythrocytosis NOS
- Hypoxemic polycythemia
- Nephrogenous polycythemia
- Polycythemia due to erythropoietin
- Polycythemia due to fall in plasma volume
- Polycythemia due to high altitude
- Polycythemia due to stress
- Polycythemia NOS
- Relative polycythemia
Excludes2 inherited from the categories above D75.1
Not part of this code, but both may be coded when both are present.
Other codes that can never be billed with D75.1
Their own Excludes1 notes name this code, so the conflict is not listed above.
Risk adjustment
No CMS-HCC V28 category: this code does not change a RAF score.
Medicare coverage
D75.1 is named in 12 Medicare coverage policies: 12 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A56199Billing and Coding: Molecular Pathology Procedures
- A56793Billing and Coding: Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases
- A57224Billing and Coding: Respiratory Care
- A57837Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Alphabetic index entries that lead here
- Erythrocytosis(megalosplenic) (secondary)
- Gaisböck's disease(polycythemia hypertonica)
- Polycythemia(secondary)
- Polycytosis cryptogenica
- Pseudopolycythemia
- Disease, diseased›Gaisböck's(polycythemia hypertonica)
- Erythremia›secondary
- Erythrocytosis›secondary
- Erythrocytosis›stress
- Polycythemia›acquired
- Polycythemia›emotional
- Polycythemia›erythropoietin
Code history
Unchanged in every release from FY2024 to FY2027.